Back to mobile site

Deciphera Pharmaceuticals (DCPH) Tops Q2 EPS by 6c

August 4, 2022 7:18 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q2 EPS of ($0.60), $0.06 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $32.5 million versus the consensus estimate of $30.58 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities